Jewell lab awarded $1.1M from U.S. Dept. of Veterans Affairs to study vaccine for multiple sclerosis
The Jewell lab has received a 4-year, $1.1M grant from the U.S. Dept. of Veterans Affairs to design and test a vaccine-like strategy for multiple sclerosis (MS). The project will harness a new idea for reprogramming malfunctioning immune cells during MS by self-assembling immune signals to control how these signals are processed during disease. The funding will support key studies in cells, pre-clinical models of MS, and in samples from human MS patients. Dr. Jewell was recently named a non-clinical scientist at the Baltimore branch of the VA, and this grant will grow collaborations with Dr. Walter Royal at the VA Multiple Sclerosis Center of Excellence-East, as well as with Dr. Jonathan Bromberg at the University of Maryland Medical School.
Thanks to the VA Biomedical Laboratory Research and Development (BLR&D) service for this outstanding support.
Professor Jewell has been named a 2016 Young Innovator by the Cellular and Molecular Bioengineering journal. Dr. Jewell and the other young innovators will present their work at a special session during the national Biomedical Engineering Society meeting in October, and will have their work featured in the September issue of the journal. Thanks to the selection committee and the special issue editors, Prof. Mike King and Prof. Tejal Desai.
Congratulations to all of the young innovators, including Dr. Steve Jay from UMD Bioengineering - go Terps!
Read more about Prof. Jewell on the team page.
Jewell Lab Blog
Check back often for current news, events, and findings